May 02, 2019

FDA Approves First Generic Naloxone Nasal SprayCDC Prescribing Guidelines Misapplied?

The FDA has approved Teva's generic naloxone nasal spray, the first for use in the community setting by individuals who have no medical training.  The approval will make the life-saving opioid overdose antidote more affordable.